SARS-CoV-2 (COVID-19) Nucleocapsid antibody
GTX135361
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameSARS-CoV-2 (COVID-19) Nucleocapsid antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- de Melo GD, Perraud V, Alvarez F, et al. Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants. Nat Commun. 2023,14(1):4485. doi: 10.1038/s41467-023-40228-7Read this paper
- Margaroli C, Fram T, Sharma NS, et al. Type I interferon-dependent IFIT3 signaling is critical for viral clearance in airway neutrophils. Res Sq. 2023,:pii: rs.3.rs-1812836. doi: 10.21203/rs.3.rs-1812836/v1.Read this paper
- Margaroli C, Benson P, Gastanadui MG, et al. Spatial transcriptomic profiling of coronary endothelial cells in SARS-CoV-2 myocarditis. Front Med (Lausanne). 2023,10:1118024. doi: 10.3389/fmed.2023.1118024Read this paper
- Yang J, Xiao Y, Lidsky PV, et al. Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2. Nat Microbiol. 2023,8(1):121-134. doi: 10.1038/s41564-022-01288-5Read this paper
- Wu CT, Lidsky PV, Xiao Y, et al. SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming. Cell. 2023,186(1):112-130.e20. doi: 10.1016/j.cell.2022.11.030Read this paper
- Niemeyer D, Stenzel S, Veith T, et al. SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression. PLoS Biol. 2022,20(11):e3001871. doi: 10.1371/journal.pbio.3001871Read this paper
- Besselink G, Schütz-Trilling A, Veerbeek J, et al. Asymmetric Mach-Zehnder Interferometric Biosensing for Quantitative and Sensitive Multiplex Detection of Anti-SARS-CoV-2 Antibodies in Human Plasma. Biosensors (Basel). 2022,12(8). doi: 10.3390/bios12080553Read this paper
- Pipolo C, Bottai D, Fuccillo E, et al. Evidence of SARS-CoV-2 in nasal brushings and olfactory mucosa biopsies of COVID-19 patients. PLoS One. 2022,17(4):e0266740. doi: 10.1371/journal.pone.0266740Read this paper
- Burkett AE, Sher SB, Patel CR, et al. Gastrointestinal Manifestations of COVID-19 Infection: Clinicopathologic Findings in Intestinal Resections Performed at Single Institution. Front Med (Lausanne). 2022,9:811546. doi: 10.3389/fmed.2022.811546Read this paper
- Kaufmann E, Khan N, Tran KA, et al. BCG vaccination provides protection against IAV but not SARS-CoV-2. Cell Rep. 2022,38(10):110502. doi: 10.1016/j.celrep.2022.110502Read this paper